HANG TIME HEADQUARTERS — We’re doing everything within our power not to go overboard after hearing the news that Andrew Bynum, the Philadelphia 76ers’ new big man, will get “another knee injection” before his regular season begins.
Bynum, after all, has been through this before, according to his agent, David Lee, who told our main man John N. Mitchell of the Philadelphia Inquirer that this is routine stuff for his client:
“Just look at it as lubrication for his knees,” Lee said of the Synvisc-One injection that Bynum will receive. The drug is used to treat knee osteoarthritis.
“He’s had them in previous years,” Lee said. “Look at it as WD-40, for lack of a better way of explaining it. He gets them at the start of the season, and he gets them at the all-star break. It’s noninvasive and has nothing to do with the treatment he received in Germany.”
In September, Bynum had injections of platelet-rich plasma in an effort to stimulate healing in arthritis-affected areas in his knees.
Everyone knows that the knees, and all of the issues associated with them, come with the package when you’re talking about Bynum. But that doesn’t make it any easier for folks in Philadelphia to deal with, especially after they broke up a playoff nucleus to gamble on Bynum being a potential franchise anchor and the new, most dominant low-post force in the Eastern Conference (what with Dwight Howard taking Bynum’s old locker room spot with the Los Angeles Lakers).
No one disputes Bynum’s talent and the fact that when he’s at his best, Howard is the only player on the planet with a chance of matching him from one of the end of the floor to the other.
Still, in Bynum we are talking about a player who has been on the floor for the full slate of 82 regular season games just once in his career. And that would explain the collective concern here at the hideout in regards to what sort of season Bynum is going to have in the red, white and blue.